COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,282 Articles (22,759 medRxiv, 8,523 bioRxiv)

Most recent first Previous |  Page 1669: Articles 16681-16690  | Next

Rapid Evolution of SARS-CoV-2 Challenges Human Defenses
Duarte, C. M., Ketcheson, D., Eguiluz, V. M., Agusti, S. R., Gracia, J. F., Jamil, T., Laiolo, E., Gojobori, T., Alam, I.
10.1101/2021.03.27.437300 — Posted: 2021-03-27 Discussion: Onsite
The RNA sensor MDA5 detects SARS-CoV-2 infection
Sampaio, N. G., Chauveau, L., Hertzog, J., Bridgeman, A., Fowler, G., Moonen, J. P., Dupont, M., Russel, R. A., Noerenberg, M., Rehwinkel, J.
10.1101/2021.03.26.437180 — Posted: 2021-03-27
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
Zhang, Y.-N., Paynter, J., Fourfouris, T., Sou, C., Ngo, T., He, L., Zhu, J.
10.1101/2021.03.26.437274 — Posted: 2021-03-27
Differential effect of corticosteroid treatment on Influenza, SARS, MERS, and SARS-CoV-2 patients: A meta-analysis and systematic review
Ali, S., Uddin, S. Z., Dewan, M. N., Moniruzzaman, M., Kabir, M. H., Islam, M. R., Monir, H., Hossan, S., Nafiz, T. N., Rashid, R., Imran, K. M.
10.1101/2021.03.22.21254104 — Posted: 2021-03-26 Discussion: Onsite
Risk of reactivation of hepatitis B virus (HBV) and tuberculosis (TB) and complications of hepatitis C virus (HCV) following Tocilizumab therapy: A systematic review to inform risk assessment in the COVID era
Campbell, C., Andersson, M., Ansari, M. A., Moswela, O., Misbah, S. A., Klenerman, P., Matthews, P. C.
10.1101/2021.03.22.21254128 — Posted: 2021-03-26
Exploring Integrated Environmental Viral Surveillance of Indoor Environments: A comparison of surface and bioaerosol environmental sampling in hospital rooms with COVID-19 patients
Dietz, L., Constant, D. A., Fretz, M., Horve, P. F., Martinez-Olsen, A., Stenson, J., Wilkes, A., Martindale, R. G., Messer, W. B., Van Den Wymelenberg, K. G.
10.1101/2021.03.26.21254416 — Posted: 2021-03-26
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States
Davis, J. T., Chinazzi, M., Perra, N., Mu, K., Pastore y Piontti, A., Ajelli, M., Dean, N. E., Gioannini, C., Litvinova, M., Merler, S., Rossi, L., Sun, K., Xiong, X., Halloran, M. E., Longini, I. M., Viboud, C., Vespignani, A.
10.1101/2021.03.24.21254199 — Posted: 2021-03-26
Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters
Mohandas, S., Yadav, P., Nyayanit, D., Shete-Aich, A., Sarkale, P., Hundekar, S., Kumar, S., Lole, K.
10.1101/2021.03.26.437153 — Posted: 2021-03-26
Occurrence of COVID-19 symptoms during SARS-CoV-2 infection defines waning of humoral immunity
Wu, J., Liang, B., Fang, Y., Wang, H., Yang, X., Shen, S., Chen, L., Li, S., Lu, S., Xiang, T., Liu, J., Le-Trilling, V. T. K., Lu, M., Yang, D., Deng, F., Dittmer, U., Trilling, M., Zheng, X.
10.1101/2021.03.26.437123 — Posted: 2021-03-26
D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1: An in silico Study
Gupta, S., Mallick, D., Banerjee, K., Sarkar, S., Lee, S. T. M., Basuchowdhuri, P., Jana, S. S.
10.1101/2021.03.26.437194 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).